BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 35362685)

  • 21. Serological diagnosis of Epstein-Barr virus infection by novel ELISAs based on recombinant capsid antigens p23 and p18.
    Färber I; Hinderer W; Rothe M; Lang D; Sonneborn HH; Wutzler P
    J Med Virol; 2001 Apr; 63(4):271-6. PubMed ID: 11241457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of semi-automated EBV IgG avidity determination for the diagnosis of infectious mononucleosis.
    Weissbrich B
    J Med Virol; 1998 Feb; 54(2):145-53. PubMed ID: 9496374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus-specific antibodies in Epstein-Barr virus-positive and -negative gastric carcinoma cases in Japan.
    Shinkura R; Yamamoto N; Koriyama C; Shinmura Y; Eizuru Y; Tokunaga M
    J Med Virol; 2000 Apr; 60(4):411-6. PubMed ID: 10686024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Epstein-Barr Virus Serological Tools for the Screening and Risk Assessment of Nasopharyngeal Carcinoma: a Large Population-based Study.
    Guo J; Cui Z; Zheng Y; Li X; Chen Y
    Pathol Oncol Res; 2020 Oct; 26(4):2185-2190. PubMed ID: 32222897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a multiplexed bead assay for assessment of Epstein-Barr virus immunologic status.
    Klutts JS; Liao RS; Dunne WM; Gronowski AM
    J Clin Microbiol; 2004 Nov; 42(11):4996-5000. PubMed ID: 15528686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Randomized Controlled Trial on Evaluation of Plasma Epstein-Barr Virus Biomarker for Early Diagnosis in Patients With Nasopharyngeal Carcinoma.
    Liu W; Li H; Sheng H; Liu X; Chi P; Wang X; Mao M
    Adv Ther; 2020 Oct; 37(10):4280-4290. PubMed ID: 32780356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection.
    Robertson P; Beynon S; Whybin R; Brennan C; Vollmer-Conna U; Hickie I; Lloyd A
    J Med Virol; 2003 Aug; 70(4):617-23. PubMed ID: 12794726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
    Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW
    Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of a multiplexed bead-based assay with an immunofluorescence and an enzyme-immuno assay for the assessment of Epstein-Barr virus serologic status.
    Devanthéry O; Meylan P
    Clin Microbiol Infect; 2010 Dec; 16(12):1776-82. PubMed ID: 20219083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved accuracy of detection of nasopharyngeal carcinoma by combined application of circulating Epstein-Barr virus DNA and anti-Epstein-Barr viral capsid antigen IgA antibody.
    Leung SF; Tam JS; Chan AT; Zee B; Chan LY; Huang DP; Van Hasselt A; Johnson PJ; Lo YM
    Clin Chem; 2004 Feb; 50(2):339-45. PubMed ID: 14684618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
    Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of new enzyme-linked fluorescent assays for detection of Epstein-Barr virus specific antibodies in routine diagnostics.
    Koidl C; Riedl R; Schweighofer B; Fett S; Bozic M; Marth E
    Wien Klin Wochenschr; 2011 Apr; 123(7-8):230-4. PubMed ID: 21451951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analytical performance evaluation of the Elecsys Epstein-Barr virus immunoassay panel.
    Schulte-Spechtel U; Berth M; Lauseker-Hao Y; Meyer-Schlinkmann K; Bohnert M; Jochum S; Schuhmann K
    Diagn Microbiol Infect Dis; 2021 Nov; 101(3):115443. PubMed ID: 34304105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of two automated instruments for Epstein-Barr virus serology in a large adult hospital and implementation of an Epstein-Barr virus nuclear antigen-based testing algorithm.
    Al Sidairi H; Binkhamis K; Jackson C; Roberts C; Heinstein C; MacDonald J; Needle R; Hatchette TF; LeBlanc JJ
    J Med Microbiol; 2017 Nov; 66(11):1628-1634. PubMed ID: 29034860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a time-resolved fluoroimmunoassay for Epstein-Barr virus viral capsid antigen IgA antibody in human serum.
    Liang QN; Chen PQ; Liu TC; Zhou JW; Chen JJ; Wu YS
    J Virol Methods; 2015 Sep; 222():16-21. PubMed ID: 25977184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of 4 methods for the serological diagnosis of Epstein-Barr virus infection using an immunofluorescence assay as the reference method.
    Koçoğlu ME; Taş T; Mengeloğlu FZ; Özsoy Ş; Bucak Ö
    Turk J Med Sci; 2014; 44(6):914-9. PubMed ID: 25552141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.
    Karray H; Ayadi W; Fki L; Hammami A; Daoud J; Drira MM; Frikha M; Jlidi R; Middeldorp JM
    J Med Virol; 2005 Apr; 75(4):593-602. PubMed ID: 15714486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
    Us T; Cetin E; Kaşifoğlu N; Kaşifoğlu T; Akgün Y
    Mikrobiyol Bul; 2011 Oct; 45(4):677-83. PubMed ID: 22090298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a time-resolved fluorescence immunoassay for Epstein-Barr virus nuclear antigen 1-immunoglobulin A in human serum.
    Chen JJ; Liu TC; Liang QN; Dong ZN; Wu YS; Li M
    J Med Virol; 2015 Nov; 87(11):1940-5. PubMed ID: 26129643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [IgA antibodies against Epstein-Barr virus capsid antigen].
    Chalupa P; Slesinger P; Krchnáková A; Prásek J
    Cas Lek Cesk; 1992 Sep; 131(17):526-9. PubMed ID: 1330312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.